Signaling pathways
-
BA7382 NAcM-OPTSummary: NAcM-OPT is an orally bioavailable cullinneddylation1 inhibitor. - BA7383 UBA5-IN-1Summary: UBA5-IN-1 is a selective inhibitor.
- BA7384 COH000Summary: COH000 is a covalent and irreversible metastable inhibitor.
- BA7385 HB007Summary: HB007 is a small ubiquitin-associated modifier 1 degrader.
- BA7386 DI-1859Summary: DI-1859 is a potent, selective, covalent inhibitor.
- BA7387 CC0651Summary: CC0651 is a human Cdc34 ubiquitin-conjugating enzyme variant inhibitor.
- BA7388 EN219Summary: EN219 is a synthetic covalent ligand with moderate specificity acting on N-terminal cysteine C8.
- BA7389 SENP1-IN-1Summary: SENP1-IN-1 is an inhibitor of specific de-SUMOized proteases.
- BA7390 EN450Summary: EN450 is a targeted cysteine-responsive covalent molecular gel degrader.
- BA7391 WS-383Summary: WS-383 is a potent, selective and reversible interaction inhibitor.